Optimization of Prostate Biopsy

Bjurlin, Marc A.; Wysock, James S.; Taneja, Samir S.

doi:10.1016/j.ucl.2014.01.011

Cited by 82 publications

(25 citation statements)

References 124 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(1,56) Common complications of prostate biopsy include hematuria, rectal bleeding, hematospermia, and infection, but these are generally self-limiting. (9,18) In recent years, infectious complications have increased significantly, largely due to an emergence of quinolone-resistant bacteria. (2,20) Judicious selection of antibiotic prophylaxis, based on local antibiograms will decrease the risk of infectious complications.…”

Section: Resultsmentioning

confidence: 99%

“…(9) This new method provides a major improvement in detection of clinically significant prostate cancer (csCaP), and decreased detection of clinically insignificant prostate cancer. (7,10–16) The objective of the present review is to explore the safety of prostate biopsy, examine current methods for prevention of complications, and discuss the role of MRI – guided prostate biopsy in improving diagnostic accuracy.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Optimizing safety and accuracy of prostate biopsy

Jones

Radtke²,

Hadaschik³

et al. 2016

Current Opinion in Urology

View full text Add to dashboard Cite

Purpose of review The objective of this article is to examine the safety of prostate biopsy and discuss the emerging role of MRI - ultrasound fusion technology in improving diagnostic accuracy. Recent findings Men undergoing prostate biopsy frequently experience minor complications, including hematospermia, hematuria, and infection. Quinolone-resistant bacteria are a growing concern; thus transperineal access or modification of antibiotic prophylaxis based on local antibiograms is now used to avoid infectious complications. Multiparametric MRI allows visualization of many prostate cancers, and by fusing MRI with realtime ultrasound, a biopsy needle can be directed by a urologist into suspicious regions of interest. Using this new method, detection of clinically significant prostate cancer (csCaP) has increased and the incidence of falsely negative biopsies has decreased. Summary Prostate biopsy is generally a safe procedure, and with attention to local patterns of antibiotic resistance, infectious complications can be minimized. MRI - ultrasound fusion has significantly improved the accuracy of prostate biopsy, allowing tracking and targeting not previously possible.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Optimizing safety and accuracy of prostate biopsy

Jones

Radtke²,

Hadaschik³

et al. 2016

Current Opinion in Urology

View full text Add to dashboard Cite

show abstract

“…По данным M. A. Bjurlin и соавт., число ложно-отрицательных результатов при применении стандарт-ной биопсии ПЖ достигает 30 %, при этом часто «про-пускается» клинически значимый рак, что приводит к выставлению ошибочной группы риска в 30 % слу-чаев и необходимости выполнения повторных биопсий, однако при повторных биопсиях количество обнару-женных очагов РПЖ еще меньше [3]. В проведенных исследованиях B. Djavan и соавт.…”

Section: Introductionunclassified

The use of MRI/ultrasound fusion biopsy in the diagnosis of clinically significant prostate cancer

Kossov¹,

Камолов²,

Абдуллин³

et al. 2017

Cancer Urology

View full text Add to dashboard Cite

Контакты: Филипп Андреевич Коссов fil-doc@yandex.ru Введение. Стандартная биопсия предстательной железы (ПЖ) с последующей гистологической верификацией в настоящее вре-мя является неотъемлемой частью диагностики рака ПЖ (РПЖ),

show abstract

“…Currently, investigations for those with elevated PSA revolve around transrectal ultrasound guided prostate biopsies. This involves taking 12 biopsy cores in a systematic approach as supported by AUA and EAU guidelines [ 4 , 5 ]. Transrectal biopsies are done in outpatient clinics under local anaesthesia.…”

Section: Introductionmentioning

confidence: 99%

The detection and upgrade rates of prostate adenocarcinoma following transperineal template-guided prostate biopsy – a tertiary referral centre experience

Muthuveloe

Telford

Viney

et al. 2016

CEJU

View full text Add to dashboard Cite

IntroductionWe aim to present transperineal template-guided prostate biopsy (template biopsy) outcomes at a tertiary referral centre. Furthermore, to identify the detection rate of prostate cancer in those with a previous negative transrectal ultrasound guided prostate biopsy and the upgrade rate of those on active surveillance for Gleason 3 + 3 = 6 prostate adenocarcinoma.Material and methodsWe conducted a prospective study of 200 consecutive men who underwent template biopsy over a 22-month period in a tertiary referral centre, using a standard 24 region template prostate biopsy technique. Indications and histology results, as well as complications, were recorded.ResultsMedian age was 67 years and median PSA was 10 ng/mL. Overall detection rate was 47%. 39.5% of cases with previous negative transrectal biopsies were found to have prostate adenocarcinoma. 47.5% of cases on active surveillance for Gleason 3 + 3 = 6 prostate adenocarcinoma were upgraded. The most frequent complication was acute urinary retention at a rate of 12.5%, however, the use of a single prophylactic dose of tamsulosin was found to be beneficial, with 13 cases needed to treat to prevent one episode.ConclusionsTemplate biopsies are safe and efficacious with an overall detection rate of 47% in the present series. Due to the high detection rate, one must consider template biopsy following one negative transrectal biopsy where there is persistent clinical suspicion. Furthermore, those considering active surveillance for Gleason 3 + 3 = 6 disease should be offered template biopsy to confirm the grade of their disease.

show abstract

Optimization of Prostate Biopsy

Cited by 82 publications

References 124 publications

Optimizing safety and accuracy of prostate biopsy

Optimizing safety and accuracy of prostate biopsy

The use of MRI/ultrasound fusion biopsy in the diagnosis of clinically significant prostate cancer

The detection and upgrade rates of prostate adenocarcinoma following transperineal template-guided prostate biopsy – a tertiary referral centre experience

Contact Info

Product

Resources

About